The global biotechnology market is experiencing significant growth fueled by government support, pandemic-related opportunities, and increased demand for clinical solutions.
Therefore, investors could consider investing in top biotech stocks Gilead Sciences, Inc. (GILD), Exelixis, Inc. (EXEL), and Incyte Corporation (INCY) for end-of-year profits. These companies boast robust profit margins.
